Ucsf clinical and translational science institute
Active Cooperative Agreement Awarded
- Award ID
- UM1TR006119
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,277,108
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date 3% complete
- Place of performance
- San Francisco, CA 94143, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded The Regents of the University of California, San Francisco a $10.277108 million Cooperative Agreement (UM1TR006119) on September 9, 2026, under Assistance Listing 93.350, National Center for Advancing Translational Sciences. The award funds the University of California, San Francisco Clinical and Translational Science Institute (CTSI), which will develop, implement, and disseminate translational science innovations across the full T0–T5 spectrum. The source describes the work as accelerating novel informatics tools, improving the efficiency of research operations, training the next generation of translational researchers, and promoting community-engaged research. It also names a central administrative unit that responds to public health emergencies, and programs in Elements B–E that each target specific translational research barriers. The recipient is administered through the Controller's Office under UEI KMH5K9V7S518. Place of performance is San Francisco, CA 94143. The period of performance runs from the September 9, 2026 award date to an ultimate completion date of June 30, 2033. The source identifies no sub-recipients for this award.
Description
- Abstract
- The university of california, SAN francisco clinical and translational science institute (CTSI) enters its third decade prepared to catalyze research in an ERA of unparalleled advances in biomedical discovery. CTSI's vision is to develop, implement, and disseminate translational science (TS) innovations across the full TS spectrum (T0-T5). Its mission is to apply TS principles to provide the tools, training, environment, resources, and partnerships that ensure the efficiency and effectiveness of translational research for the benefit of all patients, communities, and public health. CTSI is an institutional and national TS leader with resources and programs that have been adopted across the ctsa consortium to accelerate novel informatics tools, improve the efficiency of research operations, train the next generation of skilled TS researchers, and promote meaningful community-engagement as essential to research endeavors. CTSI's 6 overall specific aims match its strategic goals (element a) and align with the ncats strategic plan 2025-30 and the national ctsa program goals. Each CTSI program (elements B-E) proposes innovations for a specific TS focus aimed at overcoming distinct roadblocks or barriers across the research lifecycle. CTSI maintains robust program evaluation to ensure that new initiatives bolster and accelerate the research enterprise. Notable areas of CTSI strength are: the application of the ncats TS framework to all training and programmatic activities; serving as a nexus for development and dissemination of pivotal innovations and novel products; and amplifying community-engaged research. CTSI will deliver on its vision and mission through achievement of the following aims/strategic goals: 1. Support an efficient and impactful hub with a nimble central administrative unit that effectively responds to public health emergencies; 2. Design, test, and disseminate innovative TS resources, tools, methods, and services to accelerate the efficiency and effectiveness of translational research; 3. Engage with partners and collaborators locally, regionally, and nationally to advance the health of all populations; 4. Develop and implement training programs that promote team science and TS careers across a multidisciplinary workforce; 5. Create, promote, and disseminate programs that achieve improvements in community and population health; and 6. Implement activities that ensure the safety, quality, and operational efficiency of clinical and translational research, including the design and conduct of clinical trials. Expected outcomes. CTSI will improve health and healthcare by delivering: • a highly trained, multidisciplinary TS workforce • meaningful improvements in community health through collaborations with public health systems, expanded community leadership, and community engagement pilot awards • efficient research operations, biobanking, and enhanced EHR-based recruitment technology • optimized learning health systems and new platforms for rapid evaluation of emerging digital technologies • advanced capacity to conduct decentralized clinical trials.
Quick answers
Who received award UM1TR006119?
UM1TR006119 was awarded to The Regents Of The University Of California. San Francisco by National Center for Advancing Translational Sciences (National Institutes of Health) on September 9, 2026.
How much is award UM1TR006119 worth?
$10,277,108 has been obligated on UM1TR006119.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award